Clinical Trials

176 enrolled

Pancreatic Neoplasms

NCT04266249 2026-03-23

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

2,175 enrolled

Breast

Anatomic Stage II Breast Cancer AJCC v8

NCT04001829 2026-03-13

Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer

249 enrolled 14 charts

Breast

Anatomic Stage I Breast Cancer AJCC v8

NCT04205968 2025-11-05

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

Phase 2 Recruiting

94 enrolled

Metastatic Small Intestinal Adenocarcinoma

NCT03694002 2025-10-30

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

21 enrolled 17 charts

Thoracic

Thymoma

NCT05042128 2024-10-22

ASCEND

158 enrolled

Pancreatic Neoplasms

NCT00062010 2023-07-07

Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer

37 enrolled 8 charts

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00010257 2023-06-29

Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma

46 enrolled 7 charts

Thoracic

Thymoma

NCT02560298 2023-06-22

InterAACT

Phase 2 Unknown

91 enrolled

Anal Canal Carcinoma, Anus Neoplasms

NCT02562716 2022-10-19

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

147 enrolled 16 charts

Pancreatic Adenocarcinoma

NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Phase 2 Withdrawn

Uterine Cervical Neoplasms, HIV Infections

NCT01042522 2022-01-25

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

Phase 2 Unknown

63 enrolled 16 charts

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

NCT00888615 2021-10-20

Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

58 enrolled 13 charts

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00309959 2019-01-08

ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

37 enrolled 7 charts

Uterine Cervical Neoplasms

NCT00467051 2018-08-29

Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors

20 enrolled 8 charts

GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Testicular Neoplasms, Carcinoma, Embryonal, Endodermal Sinus Tumor

NCT01921751 2018-07-13

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Phase 2 Terminated

20 enrolled 9 charts

Pancreatic Neoplasms

NCT00499252 2018-01-11

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

51 enrolled 8 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00004221 2017-08-09

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer

Phase 2 Terminated

12 enrolled

Ovarian Neoplasms

NCT00856492 2017-06-27

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer